Psychiatry AtlasMedication guide · United States

Sleep-onset medicine that acts on melatonin receptors

Ramelteon (Rozerem)

Generic name
ramelteon
Brand names
Rozerem
Medication class
Sleep-onset medicine that acts on melatonin receptors
Forms covered
Rozerem oral tablets

Article updated: 2026-10-24 · Sources last checked: 2026-11-05

Medication Safety Alerts

Look-alike / sound-alike name

  • Rozerem can be confused with Razadyne. Razadyne is a historical US brand name.
  • Rozerem can be confused with Remeron.

Ramelteon (Rozerem) helps adults who have trouble falling asleep. It acts on the body’s melatonin signaling system and is not a controlled substance.

What to expect: The intended benefit is falling asleep more easily, not a guarantee of uninterrupted sleep.

Warning signs
Sources last checked:
2026-11-05

What is this medicine used for?

FDA-approved uses

  • Insomnia characterized by difficulty with sleep onset — Adults. Pediatric safety and effectiveness are not established.Rozerem oral tablets.

What should I expect?

The intended benefit is falling asleep more easily, not a guarantee of uninterrupted sleep. Its bedtime effect should be assessed alongside next-day alertness.

If insomnia has not improved after 7–10 days, or worsens at any time, contact the prescriber so other causes can be considered. Do not take extra because a night is difficult.

How do I take it safely?

Take within 30 minutes before bed, with time for a full 7–8 hours of sleep. Swallow whole. Do not take with or immediately after a high-fat meal, and limit activity afterward to preparing for bed.

Do not combine with fluvoxamine. Review other antidepressants, antifungals, donepezil, doxepin and enzyme-inducing medicines. Avoid alcohol and unreviewed sleep medicines or sedatives.

Discuss breathing disease, sleep apnea, liver disease, depression and hormone-related symptoms. Severe liver impairment and severe obstructive sleep apnea are important restrictions. Do not restart after ramelteon-related swelling of the tongue or throat.

Report sleep-driving or other activities while not fully awake immediately; the clinician should reconsider treatment. Assess next-day alertness and falls. Hormone tests are selected for symptoms rather than routinely required for everyone.

Do not make up a missed bedtime dose during the day or double. Studies did not identify a withdrawal syndrome, but persistent insomnia still needs a plan when treatment stops.

Discuss pregnancy and breastfeeding. Monitor an exposed infant for sleepiness or feeding problems; the label describes expressing and discarding milk through 25 hours after a dose as an option to reduce exposure. Pediatric use is not established.

What side effects should I know about?

  • Sleepiness, dizziness, fatigue, nausea and worsened insomnia.

Tell your prescriber about effects that are persistent, troublesome, or interfere with daily life.

Which warning signs need help?

  • Contact the prescriber immediately for sleepwalking, sleep-driving or other activities while not fully awake; treatment needs reconsideration.
  • New suicidal thoughts or a severe mood or behavior change needs immediate clinical contact; get emergency help if someone cannot stay safe.
  • Get emergency help for trouble breathing, swelling of the tongue or throat, collapse, a seizure or inability to wake. Suspected overdose needs immediate poison-center or emergency advice; do not wait for symptoms.

What else should I know to stay safe?

  • Do not combine with fluvoxamine or restart after ramelteon-related angioedema. Severe liver impairment and severe obstructive sleep apnea are important restrictions; review other breathing disease, depression and hormone-related symptoms.
  • Avoid alcohol and unreviewed sedatives or sleep medicines. Other antidepressants, antifungals, donepezil, doxepin and enzyme-inducing medicines need interaction review. Monitor next-day alertness and falls; hormone tests may be needed if symptoms develop.
  • Discuss pregnancy and breastfeeding; an exposed infant needs observation for sleepiness or feeding problems. The label describes expressing and discarding milk through 25 hours after a dose as an option to reduce exposure. Pediatric use is not established.

Urgent help and crisis support · Emergency & Crisis Resources (US)

What can help day to day?

  • Not being a controlled substance does not mean it is free of sedation, interactions or unusual sleep behavior.
  • Meal timing matters: a high-fat meal changes absorption and can delay the intended bedtime effect.
  • New menstrual changes, nipple discharge or sexual symptoms deserve a discussion because ramelteon can affect reproductive hormones.

How does it work?

Ramelteon activates receiving sites in the brain that normally respond to melatonin, one of the body’s chemical signals involved in the timing of sleep. By acting at these sites, it can help the brain move toward sleep. Its effect is connected to the body’s daily sleep and wake rhythm.

Explore medication science

How was this medicine developed?

Rozerem received FDA approval in 2005. It offered an insomnia approach directed at melatonin receptors rather than the GABA signaling system targeted by several other sleep medicines.

How do I say the name?

Ramelteon: ram-EL-tee-on. Capital letters show the stressed syllable.

Sources and References

Sources support the U.S. products described here. Product instructions can differ; use the information supplied with your own medicine.

  1. ramelteon: current US prescribing information
  2. ramelteon: FDA approval history
  3. ramelteon: patient medicine information
  4. ramelteon: FDA prescribing information
  5. Rozerem: Package Insert / Prescribing Information / MOA
  6. lemborexant: current prescribing information
  7. Ramelteon: verified neutral parent, PubChem CID 208902
  8. Brain Basics: Understanding Sleep — mechanism explanation

    Scope: Mechanism explanation only. Source sections checked: Sleep Mechanisms..

  9. ISMP List of Confused Drug Names

Giving medicine safely to children: family guide (PDF, 3 pages)

How information is checked

Was this article helpful?

Was this article helpful?

Sends your choice, article identifier, edition and optional issue to Psychiatry Atlas. No name, email or medical details are requested. Daily network codes help prevent spam; hosting may process technical information. This is not a promise of anonymity. Privacy details.

Enable JavaScript to send feedback.

Suggest a missing topic or describe a correction. Please keep personal medical information out of website feedback.

Back to top